409 related articles for article (PubMed ID: 8202552)
21. Protein modification by the degradation products of ascorbate: formation of a novel pyrrole from the Maillard reaction of L-threose with proteins.
Nagaraj RH; Monnier VM
Biochim Biophys Acta; 1995 Nov; 1253(1):75-84. PubMed ID: 7492603
[TBL] [Abstract][Full Text] [Related]
22. Formation and elimination of pyrraline in the Maillard reaction in a saccharide-lysine model system.
Liang Z; Li L; Fu Q; Zhang X; Xu Z; Li B
J Sci Food Agric; 2016 May; 96(7):2555-64. PubMed ID: 26260362
[TBL] [Abstract][Full Text] [Related]
23. Ovalbumin modified with pyrraline, a Maillard reaction product, shows enhanced T-cell immunogenicity.
Heilmann M; Wellner A; Gadermaier G; Ilchmann A; Briza P; Krause M; Nagai R; Burgdorf S; Scheurer S; Vieths S; Henle T; Toda M
J Biol Chem; 2014 Mar; 289(11):7919-28. PubMed ID: 24505139
[TBL] [Abstract][Full Text] [Related]
24. The role of the Maillard reaction in other pathologies: Alzheimer's disease.
Colaco CA; Ledesma MD; Harrington CR; Avila J
Nephrol Dial Transplant; 1996; 11 Suppl 5():7-12. PubMed ID: 9044299
[TBL] [Abstract][Full Text] [Related]
25. Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons.
Kimura T; Takamatsu J; Ikeda K; Kondo A; Miyakawa T; Horiuchi S
Neurosci Lett; 1996 Apr; 208(1):53-6. PubMed ID: 8731173
[TBL] [Abstract][Full Text] [Related]
26. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia.
Monnier VM; Sell DR; Nagaraj RH; Miyata S; Grandhee S; Odetti P; Ibrahim SA
Diabetes; 1992 Oct; 41 Suppl 2():36-41. PubMed ID: 1526333
[TBL] [Abstract][Full Text] [Related]
27. Protein Repair from Glycation by Glyoxals by the DJ-1 Family Maillard Deglycases.
Mihoub M; Abdallah J; Richarme G
Adv Exp Med Biol; 2017; 1037():133-147. PubMed ID: 29147907
[TBL] [Abstract][Full Text] [Related]
28. Stability of Individual Maillard Reaction Products in the Presence of the Human Colonic Microbiota.
Hellwig M; Bunzel D; Huch M; Franz CM; Kulling SE; Henle T
J Agric Food Chem; 2015 Aug; 63(30):6723-30. PubMed ID: 26186075
[TBL] [Abstract][Full Text] [Related]
29. Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds.
Henle T; Deppisch R; Beck W; Hergesell O; Hänsch GM; Ritz E
Nephrol Dial Transplant; 1999 Aug; 14(8):1968-75. PubMed ID: 10462279
[TBL] [Abstract][Full Text] [Related]
30. Urinary pyrraline as a biochemical marker of non-oxidative Maillard reactions in vivo.
Portero-Otín M; Pamplona R; Bellmunt MJ; Bergua M; Nagaraj RH; Prat J
Life Sci; 1997; 60(4-5):279-87. PubMed ID: 9010483
[TBL] [Abstract][Full Text] [Related]
31. Nepsilon-(Carboxymethyl)lysine and 3-DG-imidazolone are major AGE structures in protein modification by 3-deoxyglucosone.
Jono T; Nagai R; Lin X; Ahmed N; Thornalley PJ; Takeya M; Horiuchi S
J Biochem; 2004 Sep; 136(3):351-8. PubMed ID: 15598892
[TBL] [Abstract][Full Text] [Related]
32. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS.
Seftel AD; Vaziri ND; Ni Z; Razmjouei K; Fogarty J; Hampel N; Polak J; Wang RZ; Ferguson K; Block C; Haas C
Urology; 1997 Dec; 50(6):1016-26. PubMed ID: 9426743
[TBL] [Abstract][Full Text] [Related]
33. Immunoelectron microscopic analyses of Maillard reaction products in bovine anterior lens capsule and Descemet's membrane.
Marion MS; Carlson EC
Biochim Biophys Acta; 1994 Apr; 1191(1):33-42. PubMed ID: 8155682
[TBL] [Abstract][Full Text] [Related]
34. Lysyl oxidase and Maillard reaction-mediated crosslinks in aging and osteoarthritic rabbit cartilage.
Pokharna HK; Monnier V; Boja B; Moskowitz RW
J Orthop Res; 1995 Jan; 13(1):13-21. PubMed ID: 7853094
[TBL] [Abstract][Full Text] [Related]
35. Formation of Peptide Bound Pyrraline in the Maillard Model Systems with Different Lys-Containing Dipeptides and Tripeptides.
Liang Z; Li L; Qi H; Wan L; Cai P; Xu Z; Li B
Molecules; 2016 Apr; 21(4):463. PubMed ID: 27070556
[TBL] [Abstract][Full Text] [Related]
36. High levels of urinary pentosidine, an advanced glycation end product, in children with acute exacerbation of atopic dermatitis: relationship with oxidative stress.
Tsukahara H; Shibata R; Ohta N; Sato S; Hiraoka M; Ito S; Noiri E; Mayumi M
Metabolism; 2003 Dec; 52(12):1601-5. PubMed ID: 14669163
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of tenilsetam on the Maillard reaction.
Shoda H; Miyata S; Liu BF; Yamada H; Ohara T; Suzuki K; Oimomi M; Kasuga M
Endocrinology; 1997 May; 138(5):1886-92. PubMed ID: 9112383
[TBL] [Abstract][Full Text] [Related]
38. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.
Castellani R; Smith MA; Richey PL; Perry G
Brain Res; 1996 Oct; 737(1-2):195-200. PubMed ID: 8930366
[TBL] [Abstract][Full Text] [Related]
39. Identification of AGE-precursors and AGE formation in glycation-induced BSA peptides.
Ahmad W; Li L; Deng Y
BMB Rep; 2008 Jul; 41(7):516-22. PubMed ID: 18682035
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons.
Horie K; Miyata T; Yasuda T; Takeda A; Yasuda Y; Maeda K; Sobue G; Kurokawa K
Biochem Biophys Res Commun; 1997 Jul; 236(2):327-32. PubMed ID: 9240434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
